Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.
2.

Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis.

Garson JA, Usher L, Al-Chalabi A, Huggett J, Day EF, McCormick AL.

Acta Neuropathol Commun. 2019 Mar 18;7(1):45. doi: 10.1186/s40478-019-0698-2.

3.

Mouse cytomegalovirus M36 and M45 death suppressors cooperate to prevent inflammation resulting from antiviral programmed cell death pathways.

Daley-Bauer LP, Roback L, Crosby LN, McCormick AL, Feng Y, Kaiser WJ, Mocarski ES.

Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2786-E2795. doi: 10.1073/pnas.1616829114. Epub 2017 Mar 14.

4.

TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.

Lowe DB, Bivens CK, Mobley AS, Herrera CE, McCormick AL, Wichner T, Sabnani MK, Wood LM, Weidanz JA.

MAbs. 2017 May/Jun;9(4):603-614. doi: 10.1080/19420862.2017.1302630.

5.

Evaluation of sequencing of HCV core/E1, NS5A and NS5B as a genotype predictive tool in comparison with commercial assays targeting 5'UTR.

McCormick AL, Macartney MJ, Abdi-Abshir I, Labbett W, Smith C, Irish D, Webster DP, Haque T.

J Clin Virol. 2015 May;66:56-9. doi: 10.1016/j.jcv.2015.03.006. Epub 2015 Mar 10.

PMID:
25866338
6.

The immunological underpinnings of vaccinations to prevent cytomegalovirus disease.

McCormick AL, Mocarski ES.

Cell Mol Immunol. 2015 Mar;12(2):170-9. doi: 10.1038/cmi.2014.120. Epub 2014 Dec 29. Review.

7.

The Efficacy of Current Treatment Options for Metastatic Cervical Cancer.

Palin HJ, McCormick AL, Sabaté E.

Value Health. 2014 Nov;17(7):A616. doi: 10.1016/j.jval.2014.08.2169. Epub 2014 Oct 26. No abstract available.

8.

Baseline drug resistance mutations are detectable in HCV genes NS3 and NS5A but not NS5B in acute and chronic HIV-coinfected patients.

McCormick AL, Moynihan L, Macartney MJ, Garcia-Diaz A, Smith C, Johnson MA, Rodger AJ, Bhagani S, Haque T, Webster DP.

Antivir Ther. 2015;20(3):361-3. doi: 10.3851/IMP2871. Epub 2014 Oct 3. No abstract available.

PMID:
25279548
9.

The utility of different bioinformatics algorithms for genotypic HIV-1 tropism testing in a large clinical cohort with multiple subtypes.

Bartlett AD, MaCartney MJ, Conibear TC, Feyertag F, Smith CJ, Johnson MA, Hyams C, Garcia-Diaz A, McCormick AL, Booth C, Robertson DL, Webster DP.

AIDS. 2014 Jul 17;28(11):1611-7. doi: 10.1097/QAD.0000000000000288.

PMID:
24785955
10.

Prevalence of baseline polymorphisms for potential resistance to NS5A inhibitors in drug-naive individuals infected with hepatitis C genotypes 1-4.

McCormick AL, Wang L, Garcia-Diaz A, Macartney MJ, Webster DP, Haque T.

Antivir Ther. 2015;20(1):81-5. doi: 10.3851/IMP2763. Epub 2014 Mar 12.

PMID:
24621453
11.

Telaprevir or boceprevir based therapy for chronic hepatitis C infection: development of resistance-associated variants in treatment failure.

Macartney MJ, Irish D, Bridge SH, Garcia-Diaz A, Booth CL, McCormick AL, Labbett W, Smith C, Velazquez C, Tanwar S, Trembling P, Jacobs M, Dusheiko G, Rosenberg W, Haque T.

Antiviral Res. 2014 May;105:112-7. doi: 10.1016/j.antiviral.2014.02.019. Epub 2014 Mar 1.

PMID:
24594347
12.

Evaluation of the Roche prototype 454 HIV-1 ultradeep sequencing drug resistance assay in a routine diagnostic laboratory.

Garcia-Diaz A, Guerrero-Ramos A, McCormick AL, Macartney M, Conibear T, Johnson MA, Haque T, Webster DP.

J Clin Virol. 2013 Oct;58(2):468-73. doi: 10.1016/j.jcv.2013.07.009. Epub 2013 Aug 15.

PMID:
23954217
13.

Cytomegalovirus vaccine strain towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells.

Cayatte C, Schneider-Ohrum K, Wang Z, Irrinki A, Nguyen N, Lu J, Nelson C, Servat E, Gemmell L, Citkowicz A, Liu Y, Hayes G, Woo J, Van Nest G, Jin H, Duke G, McCormick AL.

J Virol. 2013 Oct;87(20):11107-20. doi: 10.1128/JVI.01554-13. Epub 2013 Aug 7.

14.

Gene products of the embedded m41/m41.1 locus of murine cytomegalovirus differentially influence replication and pathogenesis.

Crosby LN, McCormick AL, Mocarski ES.

Virology. 2013 Feb 20;436(2):274-83. doi: 10.1016/j.virol.2012.12.002. Epub 2013 Jan 5.

15.

Multiplicity-dependent activation of a serine protease-dependent cytomegalovirus-associated programmed cell death pathway.

McCormick AL, Roback L, Wynn G, Mocarski ES.

Virology. 2013 Jan 20;435(2):250-7. doi: 10.1016/j.virol.2012.08.042. Epub 2012 Nov 14.

16.

Antiviral T cell response triggers cytomegalovirus hepatitis in mice.

Livingston-Rosanoff D, Daley-Bauer LP, Garcia A, McCormick AL, Huang J, Mocarski ES.

J Virol. 2012 Dec;86(23):12879-90. doi: 10.1128/JVI.01752-12. Epub 2012 Sep 19.

17.

Mating disruption of Guatemalan potato moth Tecia solanivora by attractive and non-attractive pheromone blends.

McCormick AL, Karlsson M, Ochoa CF, Proffit M, Bengtsson M, Zuluaga MV, Fukumoto T, Oehlschlager C, Prado AM, Witzgall P.

J Chem Ecol. 2012 Jan;38(1):63-70. doi: 10.1007/s10886-011-0051-0. Epub 2011 Dec 24.

PMID:
22198735
18.

Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis.

Mikhailidis DP, Lawson RW, McCormick AL, Sibbring GC, Tershakovec AM, Davies GM, Tunceli K.

Curr Med Res Opin. 2011 Jun;27(6):1191-210. doi: 10.1185/03007995.2011.571239. Epub 2011 Apr 7. Review.

PMID:
21473671
19.

Viral modulation of the host response to infection.

McCormick AL, Mocarski Jr. ES.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 21.

20.

Impact of the N348I mutation in HIV-1 reverse transcriptase on nonnucleoside reverse transcriptase inhibitor resistance in non-subtype B HIV-1.

McCormick AL, Parry CM, Crombe A, Goodall RL, Gupta RK, Kaleebu P, Kityo C, Chirara M, Towers GJ, Pillay D.

Antimicrob Agents Chemother. 2011 Apr;55(4):1806-9. doi: 10.1128/AAC.01197-10. Epub 2011 Jan 31.

21.

Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays.

Gupta RK, Kohli A, McCormick AL, Towers GJ, Pillay D, Parry CM.

AIDS. 2010 Jul 17;24(11):1651-5.

22.

Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting.

McCormick AL, Goodall RL, Joyce A, Ndembi N, Chirara M, Katundu P, Walker S, Yirrell D, Gilks CF, Pillay D; DART Virology Group and Trial Team.

J Acquir Immune Defic Syndr. 2010 Jun;54(2):215-6. doi: 10.1097/QAI.0b013e3181cc1058. No abstract available.

PMID:
20505473
23.

The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages.

McCormick AL, Roback L, Livingston-Rosanoff D, St Clair C.

J Virol. 2010 May;84(10):5108-23. doi: 10.1128/JVI.01345-09. Epub 2010 Mar 10.

24.

Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1.

Parry CM, Kohli A, Boinett CJ, Towers GJ, McCormick AL, Pillay D.

J Virol. 2009 Sep;83(18):9094-101. doi: 10.1128/JVI.02356-08. Epub 2009 Jul 8.

25.

HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA).

McCormick AL, Roback L, Mocarski ES.

PLoS Pathog. 2008 May 9;4(5):e1000063. doi: 10.1371/journal.ppat.1000063.

26.

Control of apoptosis by human cytomegalovirus.

McCormick AL.

Curr Top Microbiol Immunol. 2008;325:281-95. Review.

PMID:
18637512
27.

Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate.

McCormick AL, Brown RH Jr, Cudkowicz ME, Al-Chalabi A, Garson JA.

Neurology. 2008 Jan 22;70(4):278-83. doi: 10.1212/01.wnl.0000297552.13219.b4.

PMID:
18209202
28.

Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxis.

Potena L, Holweg CT, Vana ML, Bashyam L, Rajamani J, McCormick AL, Cooke JP, Valantine HA, Mocarski ES.

J Clin Microbiol. 2007 Jun;45(6):1804-10. Epub 2007 Apr 4. Erratum in: J Clin Microbiol. 2008 Dec;46(12):4121.

29.
30.

An interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming.

Nimal S, McCormick AL, Thomas MS, Heath AW.

Vaccine. 2005 Jun 10;23(30):3984-90. Epub 2005 Apr 2.

PMID:
15917120
31.

CD40 antibody as an adjuvant induces enhanced T cell responses.

Carlring J, Barr TA, McCormick AL, Heath AW.

Vaccine. 2004 Sep 3;22(25-26):3323-8.

PMID:
15308355
34.

A potent adjuvant effect of CD40 antibody attached to antigen.

Barr TA, McCormick AL, Carlring J, Heath AW.

Immunology. 2003 May;109(1):87-92.

35.
36.

Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.

McCormick AL, Thomas MS, Heath AW.

J Infect Dis. 2001 Dec 1;184(11):1423-30. Epub 2001 Nov 13.

PMID:
11709784
37.

A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation.

Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, Goldmacher VS.

Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7829-34. Epub 2001 Jun 26.

38.
39.

The nucleotidylylation of herpes simplex virus 1 regulatory protein alpha22 by human casein kinase II.

Mitchell C, Blaho JA, McCormick AL, Roizman B.

J Biol Chem. 1997 Oct 3;272(40):25394-400.

40.

Enhancement of immunogenicity of recombinant antigens by production of a cytokine-antigen fusion protein for vaccination.

McCormick AL, Thomas MS, Heath AW.

Biochem Soc Trans. 1997 May;25(2):297S. No abstract available.

PMID:
9191341
42.

Human cytomegalovirus ICP22, the product of the HWLF1 reading frame, is an early nuclear protein that is released from cells.

Mocarski ES, Pereira L, McCormick AL.

J Gen Virol. 1988 Oct;69 ( Pt 10):2613-21.

PMID:
2844970
43.

Supplemental Content

Loading ...
Support Center